Personensuche
Personensuche
Es wurde 1 Person gefunden.
Aktuelle Veranstaltungen
-
2024 WS
Vergangene Veranstaltungen (max. 10)
-
2023 WS
-
2022 SS
-
2021 WS
-
2021 SS
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Comprehensive biomarker diagnostics of unfavorable cancer of unknown primary to identify patients eligible for precision medical therapiesIn: European Journal of Cancer (EJC) Jg. 200 (2024) 113540Online Volltext: dx.doi.org/ (Open Access)
-
Fibroblast Activation Protein α-Directed Imaging and Therapy of Solitary Fibrous TumorIn: Journal of Nuclear Medicine (JNM) Jg. 65 (2024) Nr. 2, S. 252 - 257Online Volltext: dx.doi.org/
-
KIT ATP-Binding Pocket/Activation Loop Mutations in GI Stromal Tumor : Emerging Mechanisms of Kinase Inhibitor EscapeIn: Journal of Clinical Oncology (JCO) Jg. 42 (2024) Nr. 12, S. 1439 - 1449Online Volltext: dx.doi.org/
-
The Impact of Cancer-Associated Fibroblasts on the Biology and Progression of Colorectal CarcinomasIn: Genes Jg. 15 (2024) Nr. 2, 209Online Volltext: dx.doi.org/ (Open Access)
-
The Role of Fibroblast Activation Protein in Glioblastoma and Gliosarcoma : A Comparison of Tissue, ⁶⁸Ga-FAPI-46 PET Data, and Survival DataIn: Journal of Nuclear Medicine (JNM) Jg. 65 (2024) Nr. 8, S. 1217 - 1223Online Volltext: dx.doi.org/
-
Understanding homologous recombination repair deficiency in biliary tract cancers : clinical implications and correlation with platinum sensitivityIn: ESMO Open Jg. 9 (2024) Nr. 8, 103630Online Volltext: dx.doi.org/ (Open Access)
-
A prognostic systemic inflammation score (SIS) in patients with advanced intrahepatic cholangiocarcinomaIn: Journal of Cancer Research and Clinical Oncology Jg. 149 (2023) Nr. 8, S. 5085 - 5094Online Volltext: dx.doi.org/ (Open Access)
-
Clinical Outcome and Treatment Sequences of Patients with Advanced Pancreatic Cancer Treated with Contemporary Chemotherapy ProtocolsIn: Oncology Research and Treatment Jg. 46 (2023) Nr. 4, S. 140 - 150Online Volltext: dx.doi.org/
-
Complete Metabolic Response to Combined Immune Checkpoint Inhibition after Progression of Metastatic Colorectal Cancer on Pembrolizumab : A Case ReportIn: International Journal of Molecular Sciences (IJMS) Jg. 24 (2023) Nr. 15, 12056Online Volltext: dx.doi.org/ (Open Access)
-
Favorable survival outcomes in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer sequentially treated with a tyrosine kinase inhibitor and osimertinib in a real-world settingIn: Journal of Cancer Research and Clinical Oncology Jg. 149 (2023) Nr. 11, S. 9243 - 9252Online Volltext: dx.doi.org/ (Open Access)
-
Fibroblast Activation Protein Inhibitor Theranostics : The Case for Use in SarcomaIn: PET Clinics Jg. 18 (2023) Nr. 3, S. 361 - 367Online Volltext: dx.doi.org/
-
Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor EntitiesIn: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 5, S. 711 - 716Online Volltext: dx.doi.org/
-
Giant middle mediastinal lesions : when tumor size correlates with mesenchymal origin-a retrospective single-center analysisIn: Mediastinum Jg. 7 (2023) 8049Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Incidental Detection of a Tenosynovial Giant Cell Tumor of the Thigh on [⁶⁸Ga]Ga-FAPI PET/CT : Presentation of an Unusual CaseIn: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 7, S. 1162 - 1163Online Volltext: dx.doi.org/
-
Precision neuro-oncology : A pilot analysis of personalized treatment in recurrent gliomaIn: Journal of Cancer Research and Clinical Oncology Jg. 149 (2023) Nr. 7, S. 3513 - 3526Online Volltext: dx.doi.org/ (Open Access)
-
Smaller panel, similar results : Genomic profiling and molecularly informed therapy in pancreatic cancerIn: ESMO Open Jg. 8 (2023) Nr. 3, 101539Online Volltext: dx.doi.org/ (Open Access)
-
68Ga-FAPI as a Diagnostic Tool in Sarcoma : Data from the 68Ga-FAPI PET Prospective Observational TrialIn: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 1, S. 89 - 95Online Volltext: dx.doi.org/ (Open Access)
-
Clinical and molecular characteristics associated with response to therapeutic PD-1/PD-L1 inhibition in advanced Merkel cell carcinomaIn: Journal for ImmunoTherapy of Cancer Jg. 10 (2022) Nr. 1, e003198Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Combined multimodal ctDNA analysis and radiological imaging for tumor surveillance in Non-small cell lung cancerIn: Translational Oncology Jg. 15 (2022) Nr. 1, 101279Online Volltext: dx.doi.org/ (Open Access)
-
Corrigendum to “Conceptual framework for precision cancer medicine in Germany: Consensus statement of the Deutsche Krebshilfe working group Molecular Diagnostics and Therapy”In: European Journal of Cancer (EJC) Jg. 162 (2022) S. 245 - 246Online Volltext: dx.doi.org/
-
GenoType CM Direct® and VisionArray Myco® for the Rapid Identification of Mycobacteria from Clinical SpecimensIn: Journal of Clinical Medicine (JCM) Jg. 11 (2022) Nr. 9, 2404Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Initial Clinical Experience with ⁹⁰Y-FAPI-46 Radioligand Therapy for Advanced-Stage Solid Tumors : A Case Series of 9 PatientsIn: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 5, S. 727 - 734Online Volltext: dx.doi.org/ (Open Access)
-
Is preoperative CT-guided biopsy a valuable tool in the diagnostic workup of patients with visceral and retroperitoneal sarcoma?In: European Journal of Radiology Jg. 155 (2022) 110470Online Volltext: dx.doi.org/
-
MCL1 as putative target in pancreatoblastomaIn: Virchows Archiv Jg. 481 (2022) Nr. 2, S. 265 - 272Online Volltext: dx.doi.org/ (Open Access)
-
Multimodal survival prediction in advanced pancreatic cancer using machine learningIn: ESMO Open Jg. 7 (2022) Nr. 5, 100555Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Patterns of Tumor Infiltrating Lymphocytes in Adenoid Cystic Carcinoma of the Head and NeckIn: Cancers Jg. 14 (2022) Nr. 6, 1383Online Volltext: dx.doi.org/ (Open Access)
-
Plasma Sequencing for Patients with GIST : Limitations and Opportunities in an Academic SettingIn: Cancers Jg. 14 (2022) Nr. 22, 5496Online Volltext: dx.doi.org/ (Open Access)
-
Prognostic Factors for Leiomyosarcoma with Isolated Metastases to the Lungs : Impact of MetastasectomyIn: Annals of Surgical Oncology Jg. 29 (2022) Nr. 7, S. 4429 - 4436Online Volltext: dx.doi.org/ (Open Access)
-
Rebiopsy in advanced non-small cell lung cancer, clinical relevance and prognostic implicationsIn: Lung Cancer Jg. 168 (2022) S. 10 - 20Online Volltext: dx.doi.org/
-
Reversible occlusion of the pulmonary vasculature by transarterial embolisation with degradable starch microspheres : preclinical assessment in a human isolated lung perfusion modelIn: European Radiology Experimental Jg. 6 (2022) Nr. 1, 6Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Transcriptome-Wide Gene Expression Profiles from FFPE Materials Based on a Nuclease Protection Assay Reveals Significantly Different Patterns between Synovial Sarcomas and Morphologic MimickersIn: Cancers Jg. 14 (2022) Nr. 19, 4737Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Treatment of RET-Positive Advanced Medullary Thyroid Cancer with Multi-Tyrosine Kinase Inhibitors : A Retrospective Multi-Center Registry AnalysisIn: Cancers Jg. 14 (2022) Nr. 14, 3405Online Volltext: dx.doi.org/ (Open Access)
-
Treatment outcome of atypical EGFR mutations in the German National Network Genomic Medicine Lung Cancer (nNGM)In: Annals of Oncology Jg. 33 (2022) Nr. 6, S. 602 - 615Online Volltext: dx.doi.org/ (Open Access)
-
An unusual lymphoid lesion mimicking meningiomaIn: Brain Pathology Jg. 31 (2021) Nr. 5, e12995Online Volltext: dx.doi.org/ (Open Access)
-
BRAF mutations and BRAF mutation functional class have no negative impact on the clinical outcome of advanced NSCLC and associate with susceptibility to immunotherapyIn: European Journal of Cancer (EJC) Jg. 149 (2021) S. 211 - 221Online Volltext: dx.doi.org/
-
Clinical and molecular practice of European thoracic pathology laboratories during the COVID-19 pandemic : The past and the near futureIn: ESMO Open Jg. 6 (2021) Nr. 1, S. 100024Online Volltext: dx.doi.org/ (Open Access)
-
Context-dependent modulation of aggressiveness of pediatric tumors by individual oncogenic RAS isoformsIn: Oncogene Jg. 40 (2021) Nr. 31, S. 4955 - 4966Online Volltext: dx.doi.org/ (Open Access)
-
Dll3 (Delta-like protein 3) expression correlates with stromal desmoplasia and lymph node metastases in medullary thyroid carcinomasIn: Endocrine Connections Jg. 10 (2021) Nr. 3, S. 283 - 289Online Volltext: dx.doi.org/ (Open Access)
-
Erratum zu Mitteilungen der Deutschen Gesellschaft für PathologieIn: Der Pathologe Jg. 42 (2021) Nr. 6, S. 625Online Volltext: dx.doi.org/ (Open Access)
-
Frequency of actionable molecular drivers in lung cancer patients with precocious brain metastasesIn: Clinical Neurology and Neurosurgery Jg. 208 (2021) 106841Online Volltext: dx.doi.org/
-
HER2 mediates clinical resistance to the KRASG¹²C inhibitor sotorasib, which is overcome by co-targeting SHP2In: European Journal of Cancer (EJC) Jg. 159 (2021) S. 16 - 23Online Volltext: dx.doi.org/
-
Konventionelles epiphysäres Chondrosarkom des Kindes- und Jugendalters : ein FallberichtIn: Der Unfallchirurg Jg. 124 (2021) Nr. 9, S. 738 - 746Online Volltext: dx.doi.org/
-
Localized Angiosarcoma, Not One Disease : A Retrospective Single-Center Study on Prognosis Depending on the Primary Site and EtiologyIn: Sarcoma Jg. 2021 (2021) 9960085Online Volltext: dx.doi.org/ (Open Access)
-
MSI testing : What should be considered?In: Der Pathologe Jg. 42 (2021) Nr. S1, S. 110 - 118Online Volltext: dx.doi.org/
-
MSI-Testung : Was ist neu? Was ist zu beachten?In: Der Pathologe Jg. 42 (2021) S. 414 - 423Online Volltext: dx.doi.org/
-
Number of metastases and their response to chemotherapy impact survival of patients with isolated lung metastases from bone-derived sarcomaIn: BMC Cancer Jg. 21 (2021) Nr. 1, 375Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Polyclonal on- And off-target resistance mutations in an EML4-ALK positive non-small cell lung cancer patient under ALK inhibitionIn: OncoTarget Jg. 12 (2021) Nr. 19, S. 1946 - 1952Online Volltext: dx.doi.org/ (Open Access)
-
Prädiktive Diagnostik für Checkpoint-InhibitorenIn: Der Pathologe Jg. 42 (2021) Nr. 4, S. 380 - 390Online Volltext: dx.doi.org/
-
Resistance to avapritinib in pdgfra-driven gist is caused by secondary mutations in the pdgfra kinase domainIn: Cancer Discovery Jg. 11 (2021) Nr. 1, S. 108 - 125Online Volltext: dx.doi.org/ (Open Access)
-
Ringversuch PD-L1 Expression bei Plattenepithelkarzinomen des Kopfes und des Halses (HNSCC)In: Der Pathologe Jg. 42 (2021) Nr. 3, S. 352 - 353Online Volltext: dx.doi.org/
-
Surgical Treatment for Primary Chest Wall Sarcoma: A Single-Institution StudyIn: Journal of Surgical Research Jg. 260 (2021) S. 149 - 154Online Volltext: dx.doi.org/
-
Tropomyosin receptor kinases in sarcomas - of joy and despairIn: Current Opinion in Oncology Jg. 33 (2021) Nr. 4, S. 336 - 344Online Volltext: dx.doi.org/
-
Tumor DNA methylation profiles correlate with response to anti-PD-1 immune checkpoint inhibitor monotherapy in sarcoma patientsIn: Journal for ImmunoTherapy of Cancer Jg. 9 (2021) Nr. 3, S. e001458Online Volltext: dx.doi.org/ (Open Access)
-
Bone metastasis of retinoblastoma five years after primary treatmentIn: American Journal of Ophthalmology Case Reports Jg. 19 (2020) 100834Online Volltext: dx.doi.org/ (Open Access)
-
Clinical response to crizotinib and emergence of resistance in lung adenocarcinoma harboring a MET c-Cbl binding site mutationIn: Lung Cancer Jg. 139 (2020) S. 165 - 168Online Volltext: dx.doi.org/
-
Complexity of PEComas : Diagnostic approach, molecular background, clinical managementIn: Der Pathologe Jg. 41 (2020) Nr. Suppl. 1, S. 9 - 19Online Volltext: dx.doi.org/ (Open Access)
-
Crizotinib in ROS1 and MET deregulated NSCLC-letterIn: Clinical Cancer Research Jg. 26 (2020) Nr. 7, S. 1774Online Volltext: dx.doi.org/ (Open Access)
-
ERK phosphorylation as a marker of RAS activity and its prognostic value in non-small cell lung cancerIn: Lung Cancer Jg. 149 (2020) S. 10 - 16Online Volltext: dx.doi.org/
-
Fibroblast growth factor receptor 1 gene amplification and protein expression in human lung cancerIn: Cancer Medicine Jg. 9 (2020) Nr. 10, S. 3574 - 3583Online Volltext: dx.doi.org/ (Open Access)
-
Fluoreszenz-in-situ-Hybridisierung bei der Diagnostik von Weichgewebs- und KnochentumorenIn: Der Pathologe Jg. 41 (2020) Nr. 6, S. 589 - 605Online Volltext: dx.doi.org/
-
Immunhistochemiebasierte prädiktive Biomarker bei LungenkarzinomenIn: Der Pathologe Jg. 41 (2020) Nr. 1, S. 21 - 31Online Volltext: dx.doi.org/
-
Influence of biopsy technique on molecular genetic tumor characterization in non-small cell lung cancer : The prospective, randomized, Single-blinded, multicenter PROFILER study protocolIn: Diagnostics Jg. 10 (2020) Nr. 7, 459Online Volltext: dx.doi.org/ (Open Access)
-
KRAS mutation status concordance between the primary tumor and the corresponding metastasis in patients with rectal cancerIn: PLoS ONE Jg. 15 (2020) Nr. 10, S. e0239806Online Volltext: dx.doi.org/ (Open Access)
-
Multimodality treatment including surgery for primary pulmonary sarcoma : Size does matterIn: Journal of Surgical Oncology Jg. 122 (2020) Nr. 3, S. 506 - 514Online Volltext: dx.doi.org/ (Open Access)
-
Pleuropulmonary Blastoma Misinterpreted as Spontaneous Pneumothorax in an InfantIn: The Annals of Thoracic Surgery Jg. 110 (2020) Nr. 1, S. e79Online Volltext: dx.doi.org/ (Open Access)
-
Statistical modelling of HER2-positivity in breast cancer : Final analyses from two large, multicentre, non-interventional studies in GermanyIn: The Breast Jg. 49 (2020) S. 246 - 253Online Volltext: dx.doi.org/ (Open Access)
-
Top-level MET gene copy number gain defines a subtype of poorly differentiated pulmonary adenocarcinomas with poor prognosisIn: Translational Lung Cancer Research Jg. 9 (2020) Nr. 3, S. 603 - 616Online Volltext: dx.doi.org/ (Open Access)
-
Defining tissue requirements for a reliable detection of tumor mutational burden (TMB) in clinical FFPE samplesIn: Journal of Clinical Oncology (JCO) Jg. 37 (2019) Nr. 15_Suppl, S. e14265 - e14265Online Volltext: dx.doi.org/
-
Epitheloide, biphasische und Mischtumoren des WeichgewebesIn: Der Pathologe Jg. 40 (2019) Nr. 4, S. 393 - 411Online Volltext: dx.doi.org/
-
Erratum zu: Der prädiktive Wert der PD-L1-DiagnostikIn: Der Pathologe Jg. 40 (2019) Nr. 3, S. 275 - 275Online Volltext: dx.doi.org/ (Open Access)
-
Erratum zu: Komplexität von PEComen : Diagnose, Molekulargenetik, klinisches ManagementIn: Der Pathologe Jg. 40 (2019) Nr. 4, S. 454 - 454Online Volltext: dx.doi.org/ (Open Access)
-
KIT-Dependent and KIT-Independent Genomic Heterogeneity of Resistance in Gastrointestinal Stromal Tumors : TORC1/2 Inhibition as Salvage StrategyIn: Molecular Cancer Therapeutics Jg. 18 (2019) Nr. 11, S. 1985 - 1996Online Volltext: dx.doi.org/ (Open Access)
-
Komplexität von PEComen : Diagnose, Molekulargenetik, klinisches ManagementIn: Der Pathologe Jg. 40 (2019) Nr. 4, S. 443 - 453Online Volltext: dx.doi.org/
-
Rundzellige SarkomeIn: Der Pathologe Jg. 40 (2019) Nr. 4, S. 366 - 380Online Volltext: dx.doi.org/
-
Systemische Therapie von Sarkomen : Neue Biomarker und TherapiestrategienIn: Der Pathologe Jg. 40 (2019) Nr. 4, S. 436 - 442Online Volltext: dx.doi.org/
-
Dramatic response of a PD-L1- positive advanced angiosarcoma of the scalp to pembrolizumabIn: JCO Precision Oncology Jg. 2 (2018)Online Volltext: dx.doi.org/
-
Context-Dependent Epigenetic Regulation of Nuclear Factor of Activated T Cells 1 in Pancreatic PlasticityIn: Gastroenterology Jg. 152 (2017) Nr. 6, S. 1507 - 1520.e15Online Volltext: dx.doi.org/ (Open Access)
-
Early clinical evaluation of FGFR1 inhibition in lung cancer : Preliminary results of a phase I study in FGFR1 amplified lung cancer patients treated with BGJ398, a pan FGFR inhibitorIn: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 137
-
Residual tumor cells are unique cellular targets in glioblastomaIn: Annals of Neurology Jg. 68 (2010) Nr. 2, S. 264 - 269Online Volltext: dx.doi.org/ (Open Access)
-
In-situ-Hybridisierung in der molekularpathologischen DiagnostikIn: Der Pathologe Jg. 41 (2020) Nr. 6, S. 561 - 562Online Volltext: dx.doi.org/ (Open Access)
-
Fibroblast activation protein alpha (FAPα) directed imaging and radioligand therapy in patients with solitary fibrous tumor (SFT)In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. Suppl. 1, P714
-
Molecular characterization of biliary tract cancer at a single comprehensive cancer center focusing on DNA damage repair genes
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany,In: Oncology Research and Treatment Jg. 46 (2023) Nr. Supplement 5: DGHO Abstracts, S. 62Online Volltext: dx.doi.org/ (Open Access) -
A randomized, multicentric phase II study of preoperative nivolumab plus relatlimab or nivolumab in patients with resectable non-small cell lung cancer (NEOpredict-Lung)
ESMO Congress 2022, 9 - 13 September 2022, Paris, France,In: Annals of Oncology Jg. 33 (2022) Nr. Supplement 7: Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022, S. S1404Online Volltext: dx.doi.org/ (Open Access) -
Target Expression and FAP-Directed Tumour Imaging in a Large, Single-Centre PET Database of 324 Patients and 21 Tumour Entities
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S119 - S120Online Volltext: dx.doi.org/ (Open Access) -
Targeting SHP2 Reverts Oncogenic Mediated Resistance to KRAS-G12C InhibitionIn: Journal of Thoracic Oncology Jg. 17 (2022) Nr. 9, S. S586 - S587Online Volltext: dx.doi.org/
-
A novel theranostic approach for sarcoma : Insights on diagnostic and therapeutic use of FAP-radioligands
Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,In: Oncology Research and Treatment Jg. 44 (2021) Nr. Supplement 2, S. 11 - 12Online Volltext: dx.doi.org/ (Open Access) -
Ga-68-FAPI for sarcoma imaging : Data from the FAPI-PET prospective observational trialIn: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. Suppl. 1, 126
-
Initial clinical experience with [Y-90]Y-FAPI-46 radioligand therapy for advanced stage solid tumorsIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. Suppl. 1, S. 290
-
MET fusions as therapeutic targets in solid tumorsIn: Annals of Oncology Jg. 32 (2021) Nr. Suppl. 5, S. 1229Online Volltext: dx.doi.org/ (Open Access)
-
Response to treatment of uncommon EGFR mutations : a retrospective analysis from the German National Network Genomic Medicine Lung Cancer (nNGM)
Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,In: Oncology Research and Treatment Jg. 44 (2021) Nr. Supplement 2, S. 3 - 4Online Volltext: dx.doi.org/ (Open Access) -
1659P AI-based grading approach identifies FNCLCC grade 3 soft tissue sarcomasIn: Annals of Oncology Jg. 31 (2020) Nr. Suppl. 4, S. S988Online Volltext: dx.doi.org/ (Open Access)
-
Comprehensive profile of platelet derived growth factor receptor alpha (PDGFRA) mutations in gastrointestinal stromal tumors
Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, USA,In: Cancer Research Jg. 80 (2020) Nr. 16: Supplement, S. 3005Online Volltext: dx.doi.org/ -
Patients with metastatic EGFR-mutated non-small cell lung cancer (NSCLC) show highly favorable outcomes with treatment sequences provided at a comprehensive cancer center
Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,In: Oncology Research and Treatment Jg. 43 (2020) Nr. Suppl. 4, S. 137Online Volltext: dx.doi.org/ (Open Access) -
The impact of needle choice on molecular analysis of ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) in NSCLCIn: European Respiratory Journal (ERJ) Jg. 56 (2020) Nr. Suppl. 64,Online Volltext: dx.doi.org/
-
Extraordinary response to a combination therapy with Dabrafenib and Trametinib in a malignant extrarenal rhabdoid tumor of the liver in adult : a call for precision oncology in sarcomas
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin, Germany,In: Oncology Research and Treatment Jg. 42 (2019) Nr. Supplement 4: Abstracts, S. 293Online Volltext: dx.doi.org/ (Open Access) -
MARkers for ImmunotherApy in sarcomas (the MARIAchIS-project) : what can we learn from responders?
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin,In: Oncology Research and Treatment Jg. 42 (2019) Nr. Supplement 4: Abstracts, S. 292Online Volltext: dx.doi.org/ (Open Access) -
Monocentric analysis to identify clinical prognostic factors for angiosarcoma
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin, Germany,In: Oncology Research and Treatment Jg. 42 (2019) Nr. Supplement 4: Abstracts, S. 138Online Volltext: dx.doi.org/ (Open Access) -
Top level MET amplification : an unfavourable subgroup in non-small cell lung cancer patients
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin, Germany,In: Oncology Research and Treatment Jg. 42 (2019) Nr. Supplement 4: Abstracts, S. 210Online Volltext: dx.doi.org/ (Open Access) -
Predictive Biomarkers and Targeted Therapies in SarcomasIn: Predictive Biomarkers in Oncology: Applications in Precision Medicine / Badve, Sunil; Kumar, George Louis (Hrsg.) 2018, S. 475 - 492Online Volltext: dx.doi.org/
-
DNA damage repair pathways in biliary tract cancer : A new target for precision medicine?
ESMO Congress 2023 ; 20 - 24 October 2023, Madrid, Spain,In: Annals of Oncology Jg. 34 (2023) Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S223Online Volltext: dx.doi.org/ -
Immuntherapie eines Mikrosatelliten-instabilen metastasierten Talgdrüsenkarzinoms der Glandula submandibularis mit Pembrolizumab
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien, Austria,In: Oncology Research and Treatment Jg. 45 (2022) Nr. Supplement 2, S. 230 - 231Online Volltext: dx.doi.org/ (Open Access) -
Evaluation of mismatch repair deficiency as predictive biomarker in novel sarcoma cell line models
Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,In: Oncology Research and Treatment Jg. 44 (2021) Nr. Supplement 2, S. 186Online Volltext: dx.doi.org/ (Open Access)